Catalyst Wire Dossier Catalyst Wire Dossier

Tilmanocept

Tilmanocept · Navidea Biopharmaceuticals
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Tilmanocept, covering 2018-08-24 to 2024-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH [Phase 1]

See pricing